Artículos de revistas
Pseudomonas Aeruginosa Infection In Patients With Cystic Fibrosis: Scientific Evidence Regarding Clinical Impact, Diagnosis, And Treatment [infecção Por Pseudomonas Aeruginosa Em Pacientes Com Fibrose Cística: Evidências Científicas Sobre O Impacto Clínico, Diagnóstico E Tratamento]
Registro en:
Jornal Brasileiro De Pneumologia. , v. 39, n. 4, p. 495 - 512, 2013.
18063713
2-s2.0-84884733385
Autor
Da Silva Filho L.V.R.F.
Ferreira F.A.
Reis F.J.C.
De Britto M.C.A.
Levy C.E.
Clark O.
Ribeiro J.D.
Institución
Resumen
Evidence-based techniques have been increasingly used in the creation of clinical guidelines and the development of recommendations for medical practice. The use of levels of evidence allows the reader to identify the quality of scientific information that supports the recommendations made by experts. The objective of this review was to address current concepts related to the clinical impact, diagnosis, and treatment of Pseudomonas aeruginosa infections in patients with cystic fibrosis. For the preparation of this review, the authors defined a group of questions that would be answered in accordance with the principles of PICO-an acronym based on questions regarding the Patients of interest, Intervention being studied, Comparison of the intervention, and Outcome of interest. For each question, a structured review of the literature was performed using the Medline database in order to identify the studies with the methodological design most appropriate to answering the question. The questions were designed so that each of the authors could write a response. A first draft was prepared and discussed by the group. Recommendations were then made on the basis of the level of scientific evidence, in accordance with the classification system devised by the Oxford Centre for Evidence-Based Medicine, as well as the level of agreement among the members of the group. 39 4 495 512 Ratjen, F., Döring, G., Cystic fibrosis (2003) Lancet, 361 (9358), pp. 681-689. , http://dx.doi.org/10.1016/S0140-6736(03)12567-6 Flume, P.A., O'Sullivan, B.P., Robinson, K.A., Goss, C.H., Mogayzel Jr., P.J., Willey-Courand, D.B., Cystic fibrosis pulmonary guidelines: Chronic medications for maintenance of lung health (2007) Am J Respir Crit Care Med, 176 (10), pp. 957-969. , http://dx.doi.org/10.1164/rccm.200705-664OC, PMid:17761616 Ratjen, F.A., Cystic fibrosis: Pathogenesis and future treatment strategies (2009) Respir Care, 54 (5), pp. 595-605. , http://dx.doi.org/10.4187/aarc0427, PMid:19393104 Lommatzsch, S.T., Aris, R., Genetics of cystic fibrosis (2009) Semin Respir Crit Care Med, 30 (5), pp. 531-538. , http://dx.doi.org/10.1055/s-0029-1238911, PMid:19760540 Ratjen, F., Diagnosing and managing infection in CF Paediatr Respir Rev. 2006;7 Suppl, 1, pp. 151-153. , http://dx.doi.org/10.1016/j.prrv.2006.04.217, PMid:16798546 Govan, J.R., Deretic, V., Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia (1996) Microbiol Rev, 60 (3), pp. 539-574. , PMid:8840786 PMCid:239456 Li, Z., Kosorok, M.R., Farrell, P.M., Laxova, A., West, S.E., Green, C.G., Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis (2005) JAMA, 293 (5), pp. 581-588. , http://dx.doi.org/10.1001/jama.293.5.581, PMid:15687313 Gibson, R.L., Burns, J.L., Ramsey, B.W., Pathophysiology and management of pulmonary infections in cystic fibrosis (2003) Am J Respir Crit Care Med, 168 (8), pp. 918-951. , http://dx.doi.org/10.1164/rccm.200304-505SO, PMid:14555458 Deschaght, P., van Daele, S., de Baets, F., Vaneechoutte, M., PCR and the detection of Pseudomonas aeruginosa in respiratory samples of CF patients. A literature review (2011) J Cyst Fibros, 10 (5), pp. 293-297. , http://dx.doi.org/10.1016/j.jcf.2011.05.004, PMid:21684819 Nixon, G.M., Armstrong, D.S., Carzino, R., Carlin, J.B., Olinsky, A., Robertson, C.F., Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis (2001) J Pediatr, 138 (5), pp. 699-704. , http://dx.doi.org/10.1067/mpd.2001.112897, PMid:11343046 Henry, R.L., Mellis, C.M., Petrovic, L., Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis (1992) Pediatr Pulmonol, 12 (3), pp. 158-161. , http://dx.doi.org/10.1002/ppul.1950120306, PMid:1641272 Taccetti, G., Campana, S., Festini, F., Mascherini, M., Döring, G., Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients (2005) Eur Respir J, 26 (3), pp. 458-461. , http://dx.doi.org/10.1183/09031936.05.00009605, PMid:16135728 The Oxford 2011 Levels of Evidence, , http://www.cebm.net/index.aspx?o=5653, CEBM Centre For Evidence Based Medicine [homepage on the Internet]. Oxford: University of Oxford. [cited 2013 Feb 11] Lee, T.W., Brownlee, K.G., Conway, S.P., Denton, M., Littlewood, J.M., Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients (2003) J Cyst Fibros, 2 (1), pp. 29-34. , http://dx.doi.org/10.1016/S1569-1993(02)00141-8 Corey, M., Survival estimates in cystic fibrosis: Snapshots of a moving target (1996) Pediatr Pulmonol, 21 (3), pp. 149-150. , http://dx.doi.org/10.1002/1099-0496(199603)21:3149::AID-PPUL19502103023.0.CO;2-C Hudson, V.L., Wielinski, C.L., Regelmann, W.E., Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years (1993) J Pediatr, 122 (6), pp. 854-860. , http://dx.doi.org/10.1016/S0022-3476(09)90007-5 Kosorok, M.R., Zeng, L., West, S.E., Rock, M.J., Splaingard, M.L., Laxova, A., Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition (2001) Pediatr Pulmonol, 32 (4), pp. 277-287. , http://dx.doi.org/10.1002/ppul.2009.abs, PMid:11568988 Emerson, J., Rosenfeld, M., McNamara, S., Ramsey, B., Gibson, R.L., Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis (2002) Pediatr Pulmonol, 34 (2), pp. 91-100. , http://dx.doi.org/10.1002/ppul.10127, PMid:12112774 Lebecque, P., Leal, T., Zylberberg, K., Reychler, G., Bossuyt, X., Godding, V., Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis (2006) J Cyst Fibros, 5 (4), pp. 237-244. , http://dx.doi.org/10.1016/j.jcf.2006.04.001, PMid:16790367 Ratjen, F., Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis (2006) Curr Opin Pulm Med, 12 (6), pp. 428-432. , http://dx.doi.org/10.1097/01.mcp.0000245712.51514.a1, PMid:17053493 Equi, A.C., Pike, S.E., Davies, J., Bush, A., Use of cough swabs in a cystic fibrosis clinic (2001) Arch Dis Child, 85 (5), pp. 438-439. , http://dx.doi.org/10.1136/adc.85.5.438, PMid:11668115 PMCid:1718986 Da Silva Filho, L.V., Tateno, A.F., Martins, K.M., Azzuz Chernishev, A.C., de Garcia, D.O., Haug, M., The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis (2007) Pediatr Pulmonol, 42 (10), pp. 938-944. , http://dx.doi.org/10.1002/ppul.20686, PMid:17722007 Hoiby, N., Flensborg, E.W., Beck, B., Friis, B., Jacobsen, S.V., Jacobsen, L., Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis (1977) Scand J Respir Dis, 58 (2), pp. 65-79. , PMid:404701 Brett, M.M., Ghoneim, A.T., Littlewood, J.M., Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: A follow-up study (1988) J Clin Microbiol, 26 (8), pp. 1565-1570. , Erratum in: J Clin Microbiol 1989;27(1):230. PMid:3139707 PMCid:266661 West, S.E., Zeng, L., Lee, B.L., Kosorok, M.R., Laxova, A., Rock, M.J., Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: Early detection by serology and assessment of risk factors (2002) JAMA, 287 (22), pp. 2958-2967. , http://dx.doi.org/10.1001/jama.287.22.2958, PMid:12052125 Kappler, M., Kraxner, A., Reinhardt, D., Ganster, B., Griese, M., Lang, T., Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis (2006) Thorax, 61 (8), pp. 684-688. , http://dx.doi.org/10.1136/thx.2005.049536, PMid:16449259 PMCid:2104684 Tramper-Stranders, G.A., van der Ent, C.K., Slieker, M.G., Terheggen-Lagro, S.W., Teding van Berkhout, F., Kimpen, J.L., Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population (2006) Thorax, 61 (8), pp. 689-693. , http://dx.doi.org/10.1136/thx.2005.054726, PMid:16601093 PMCid:2104678 Ratjen, F., Walter, H., Haug, M., Meisner, C., Grasemann, H., Döring, G., Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients (2007) Pediatr Pulmonol, 42 (3), pp. 249-255. , http://dx.doi.org/10.1002/ppul.20562, PMid:17243185 Weisner, A.M., Chart, H., Bush, A., Davies, J.C., Pitt, T.L., Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis (2007) J Med Microbiol, 56 (PART 5), pp. 670-674. , http://dx.doi.org/10.1099/jmm.0.46833-0, PMid:17446292 Pressler, T., Karpati, F., Granström, M., Knudsen, P.K., Lindblad, A., Hjelte, L., Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods (2009) J Cyst Fibros, 8 (1), pp. 37-42. , http://dx.doi.org/10.1016/j.jcf.2008.08.002, PMid:18835753 Milagres, L.G., Castro, T.L., Garcia, D., Cruz, A.C., Higa, L., Folescu, T., Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis (2009) Pediatr Pulmonol, 44 (4), pp. 392-401. , http://dx.doi.org/10.1002/ppul.21022, PMid:19283764 Hayes Jr., D., Farrell, P.M., Li, Z., West, S.E., Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening (2010) Pediatr Pulmonol, 45 (1), pp. 55-61. , http://dx.doi.org/10.1002/ppul.21083, PMid:20025049 PMCid:2924665 Douglas, T.A., Brennan, S., Berry, L., Winfield, K., Wainwright, C.E., Grimwood, K., Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis (2010) Thorax, 65 (11), pp. 985-990. , http://dx.doi.org/10.1136/thx.2009.132845, PMid:20889526 Wainwright, C.E., Vidmar, S., Armstrong, D.S., Byrnes, C.A., Carlin, J.B., Cheney, J., Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: A randomized trial (2011) JAMA, 306 (2), pp. 163-171. , http://dx.doi.org/10.1001/jama.2011.954, PMid:21750293 Littlewood, J.M., Miller, M.G., Ghoneim, A.T., Ramsden, C.H., Nebulised colomycin for early pseudomonas colonisation in cystic fibrosis (1985) Lancet, 1 (8433), p. 865. , http://dx.doi.org/10.1016/S0140-6736(85)92222-6 Valerius, N.H., Koch, C., Høiby, N., Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment (1991) Lancet, 338 (8769), pp. 725-726. , http://dx.doi.org/10.1016/0140-6736(91)91446-2 Munck, A., Bonacorsi, S., Mariani-Kurkdjian, P., Lebourgeois, M., Gérardin, M., Brahimi, N., Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization (2001) Pediatr Pulmonol, 32 (4), pp. 288-292. , http://dx.doi.org/10.1002/ppul.1121, PMid:11568989 Gibson, R.L., Emerson, J., McNamara, S., Burns, J.L., Rosenfeld, M., Yunker, A., Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis (2003) Am J Respir Crit Care Med, 167 (6), pp. 841-849. , http://dx.doi.org/10.1164/rccm.200208-855OC, PMid:12480612 Davidson, A.G., Chilvers, M.A., Lillquist, Y.P., Effects of a Pseudomonas aeruginosa eradication policy in a cystic fibrosis clinic (2012) Curr Opin Pulm Med, 18 (6), pp. 615-621. , http://dx.doi.org/10.1097/MCP.0b013e328358f5a2, PMid:22990661 Ratjen, F., Munck, A., Kho, P., Angyalosi, G., ELITE Study Group. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: The ELITE trial (2010) Thorax, 65 (4), pp. 286-291. , http://dx.doi.org/10.1136/thx.2009.121657, PMid:19996339 Treggiari, M.M., Retsch-Bogart, G., Mayer-Hamblett, N., Khan, U., Kulich, M., Kronmal, R., Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis (2011) Arch Pediatr Adolesc Med, 165 (9), pp. 847-856. , http://dx.doi.org/10.1001/archpediatrics.2011.136, PMid:21893650 Langton Hewer, S.C., Smyth, A.R., Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis (2009) Cochrane Database Syst Rev, (4), pp. CD004197. , PMid:19821321 Collaco, J.M., Green, D.M., Cutting, G.R., Naughton, K.M., Mogayzel Jr., P.J., Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes (2010) Am J Respir Crit Care Med, 182 (9), pp. 1137-1143. , http://dx.doi.org/10.1164/rccm.201001-0057OC, PMid:20581166 PMCid:3001256 Fuchs, H.J., Borowitz, D.S., Christiansen, D.H., Morris, E.M., Nash, M.L., Ramsey, B.W., Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group (1994) N Engl J Med, 331 (10), pp. 637-642. , http://dx.doi.org/10.1056/NEJM199409083311003, PMid:7503821 Rosenfeld, M., Emerson, J., Williams-Warren, J., Pepe, M., Smith, A., Montgomery, A.B., Defining a pulmonary exacerbation in cystic fibrosis (2001) J Pediatr, 139 (3), pp. 359-365. , http://dx.doi.org/10.1067/mpd.2001.117288, PMid:11562614 Dakin, C., Henry, R.L., Field, P., Morton, J., Defining an exacerbation of pulmonary disease in cystic fibrosis (2001) Pediatr Pulmonol, 31 (6), pp. 436-442. , http://dx.doi.org/10.1002/ppul.1072, PMid:11389576 Flume, P.A., Mogayzel Jr., P.J., Robinson, K.A., Goss, C.H., Rosenblatt, R.L., Kuhn, R.J., Cystic fibrosis pulmonary guidelines: Treatment of pulmonary exacerbations (2009) Am J Respir Crit Care Med, 180 (9), pp. 802-808. , http://dx.doi.org/10.1164/rccm.200812-1845PP, PMid:19729669 Stenbit, A.E., Flume, P.A., Pulmonary exacerbations in cystic fibrosis (2011) Curr Opin Pulm Med, 17 (6), pp. 442-447. , PMid:21881509 Bilton, D., Canny, G., Conway, S., Dumcius, S., Hjelte, L., Proesmans, M., Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials (2011) J Cyst Fibros, 10 (SUPPL. 2), pp. 79-81. , http://dx.doi.org/10.1016/S1569-1993(11)60012-X Balaguer, A., De Dios, G.J., Home versus hospital intravenous antibiotic therapy for cystic fibrosis (2012) Cochrane Database Syst Rev, 3, pp. CD001917. , PMid:22419283 Smyth, A., Elborn, J.S., Exacerbations in cystic fibrosis: 3. Management (2008) Thorax, 63 (2), pp. 180-184. , http://dx.doi.org/10.1136/thx.2006.060905, PMid:18234661 Smyth, A., Knox, A., Twice vs three times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis (2011) J Cyst Fibros, 10 (5), p. 383. , http://dx.doi.org/10.1016/j.jcf.2011.03.010, PMid:21507733 Breidenstein, E.B., de la Fuente-Nú-ez, C., Hancock, R.E., Pseudomonas aeruginosa: All roads lead to resistance (2011) Trends Microbiol, 19 (8), pp. 419-426. , http://dx.doi.org/10.1016/j.tim.2011.04.005, PMid:21664819 Cheng, K., Smyth, R.L., Govan, J.R., Doherty, C., Winstanley, C., Denning, N., Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic (1996) Lancet, 348 (9028), pp. 639-642. , http://dx.doi.org/10.1016/S0140-6736(96)05169-0 Elphick, H.E., Tan, A., Single versus combination intravenous antibiotic therapy for people with cystic fibrosis (2005) Cochrane Database Syst Rev, (2), pp. CD002007. , PMid:15846627 Bosso, J.A., Saxon, B.A., Matsen, J.M., Comparative activity of cefepime, alone and in combination, against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients (1991) Antimicrob Agents Chemother, 35 (4), pp. 783-784. , http://dx.doi.org/10.1128/AAC.35.4.783, PMid:1906264 PMCid:245101 Tré-Hardy, M., Nagant, C., El-Manssouri, N., Vanderbist, F., Traore, H., Vaneechoutte, M., Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model (2010) Antimicrob Agents Chemother, 54 (10), pp. 4409-4415. , http://dx.doi.org/10.1128/AAC.00372-10, PMid:20696878 PMCid:2944582 Leroy, A., Humbert, G., Oksenhendler, G., Fillastre, J.P., Pharmacokinetics of aminoglycosides in subjects with normal and impaired renal function (1978) Antibiot Chemother, 25, pp. 163-180. , PMid:352252 Kovarik, J.M., Hoepelman, I.M., Verhoef, J., Once-daily aminoglycoside administration: New strategies for an old drug (1989) Eur J Clin Microbiol Infect Dis, 8 (9), pp. 761-769. , http://dx.doi.org/10.1007/BF02185842, PMid:2512146 Freeman, C.D., Nicolau, D.P., Belliveau, P.P., Nightingale, C.H., Once-daily dosing of aminoglycosides: Review and recommendations for clinical practice (1997) J Antimicrob Chemother, 39 (6), pp. 677-686. , http://dx.doi.org/10.1093/jac/39.6.677, PMid:9222035 Contopoulos-Ioannidis, D.G., Giotis, N.D., Baliatsa, D.V., Ioannidis, J.P., Extended-interval aminoglycoside administration for children: A meta-analysis (2004) Pediatrics, 114 (1), pp. 111-118. , http://dx.doi.org/10.1542/peds.114.1.e111, PMid:15231982 Smyth, A.R., Bhatt, J., Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis (2012) Cochrane Database Syst Rev, 2, pp. CD002009. , PMid:22336782 Plummer, A., Wildman, M., Duration of intravenous antibiotic therapy in people with cystic fibrosis (2011) Cochrane Database Syst Rev, 1, pp. CD006682. , PMid:21249681 Vandevanter, D.R., O'Riordan, M.A., Blumer, J.L., Konstan, M.W., Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations (2010) Respir Res, 11, p. 137. , http://dx.doi.org/10.1186/1465-9921-11-137, PMid:20925941 PMCid:2959026 Hodson, M.E., Penketh, A.R., Batten, J.C., Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis (1981) Lancet, 2 (8256), pp. 1137-1139. , http://dx.doi.org/10.1016/S0140-6736(81)90588-2 Szaff, M., Høiby, N., Flensborg, E.W., Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection (1983) Acta Paediatr Scand, 72 (5), pp. 651-657. , http://dx.doi.org/10.1111/j.1651-2227.1983.tb09789.x, PMid:6637463 Ramsey, B.W., Dorkin, H.L., Eisenberg, J.D., Gibson, R.L., Harwood, I.R., Kravitz, R.M., Efficacy of aerosolized tobramycin in patients with cystic fibrosis (1993) N Engl J Med, 328 (24), pp. 1740-1746. , http://dx.doi.org/10.1056/NEJM199306173282403, PMid:8497284 Ramsey, B.W., Pepe, M.S., Quan, J.M., Otto, K.L., Montgomery, A.B., Williams-Warren, J., Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group (1999) N Engl J Med, 340 (1), pp. 23-30. , http://dx.doi.org/10.1056/NEJM199901073400104, PMid:9878641 Maclusky, I.B., Gold, R., Corey, M., Levison, H., Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa (1989) Pediatr Pulmonol, 7 (1), pp. 42-48. , http://dx.doi.org/10.1002/ppul.1950070110, PMid:2505216 Murphy, T.D., Anbar, R.D., Lester, L.A., Nasr, S.Z., Nickerson, B., Vandevanter, D.R., Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease (2004) Pediatr Pulmonol, 38 (4), pp. 314-320. , http://dx.doi.org/10.1002/ppul.20097, PMid:15334509 (2009) Antibiotic Treatment For Cystic Fibrosis, , https://www.cysticfibrosis.org.uk/media/82010/CD_Antibiotic_treatment_for_CF_May_09.pdf, Cystic Fibrosis Trust [homepage on the Internet]. Bromley: Cystic Fibrosis Trust. [cited 2013 Feb 11], [Adobe Acrobat document, 102p.] Hodson, M.E., Gallagher, C.G., Govan, J.R., A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis (2002) Eur Respir J, 20 (3), pp. 658-664. , http://dx.doi.org/10.1183/09031936.02.00248102, PMid:12358344 McCoy, K.S., Quittner, A.L., Oermann, C.M., Gibson, R.L., Retsch-Bogart, G.Z., Montgomery, A.B., Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis (2008) Am J Respir Crit Care Med, 178 (9), pp. 921-928. , http://dx.doi.org/10.1164/rccm.200712-1804OC, PMid:18658109 PMCid:2577727 Oermann, C.M., Retsch-Bogart, G.Z., Quittner, A.L., Gibson, R.L., McCoy, K.S., Montgomery, A.B., An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis (2010) Pediatr Pulmonol, 45 (11), pp. 1121-1134. , http://dx.doi.org/10.1002/ppul.21301, PMid:20672296 Konstan, M.W., Flume, P.A., Kappler, M., Chiron, R., Higgins, M., Brockhaus, F., Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial (2011) J Cyst Fibros, 10 (1), pp. 54-61. , http://dx.doi.org/10.1016/j.jcf.2010.10.003, PMid:21075062 Geller, D.E., Flume, P.A., Staab, D., Fischer, R., Loutit, J.S., Conrad, D.J., Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa (2011) Am J Respir Crit Care Med, 183 (11), pp. 1510-1516. , http://dx.doi.org/10.1164/rccm.201008-1293OC, PMid:21471106 Ryan, G., Singh, M., Dwan, K., Inhaled antibiotics for long-term therapy in cystic fibrosis (2011) Cochrane Database Syst Rev, (3), pp. CD001021 Sawicki, G.S., Tiddens, H., Managing treatment complexity in cystic fibrosis: Challenges and opportunities (2012) Pediatr Pulmonol, 47 (6), pp. 523-533. , http://dx.doi.org/10.1002/ppul.22546, PMid:22467341 Robinson, P., Cystic fibrosis (2001) Thorax, 56 (3), pp. 237-241. , http://dx.doi.org/10.1136/thorax.56.3.237, PMid:11182019 PMCid:1758774 Bell, S.C., Robinson, P.J., Exacerbations in cystic fibrosis: 2. prevention (2007) Thorax, 62 (8), pp. 723-732. , http://dx.doi.org/10.1136/thx.2006.060897, PMid:17687099 PMCid:2117269 Sawicki, G.S., Sellers, D.E., Robinson, W.M., High treatment burden in adults with cystic fibrosis: Challenges to disease self-management (2009) J Cyst Fibros, 8 (2), pp. 91-96. , http://dx.doi.org/10.1016/j.jcf.2008.09.007, PMid:18952504 PMCid:2680350 Milgrom, H., Bender, B., Ackerson, L., Bowry, P., Smith, B., Rand, C., Noncompliance and treatment failure in children with asthma (1996) J Allergy Clin Immunol, 98 (6 PART 1), pp. 1051-1057. , http://dx.doi.org/10.1016/S0091-6749(96)80190-4 Ievers, C.E., Brown, R.T., Drotar, D., Caplan, D., Pishevar, B.S., Lambert, R.G., Knowledge of physician prescriptions and adherence to treatment among children with cystic fibrosis and their mothers (1999) J Dev Behav Pediatr, 20 (5), pp. 335-343. , http://dx.doi.org/10.1097/00004703-199910000-00008, PMid:10533992 Rau, J.L., Determinants of patient adherence to an aerosol regimen (2005) Respir Care, 50 (10), pp. 1346-1356. , discussion 1357-9. PMid:16185370 Digirolamo, A.M., Quittner, A.L., Ackerman, V., Stevens, J., Identification and assessment of ongoing stressors in adolescents with a chronic illness: An application of the behavior-analytic model (1997) J Clin Child Psychol, 26 (1), pp. 53-66. , http://dx.doi.org/10.1207/s15374424jccp2601_6, PMid:9118176 Gudas, L.J., Koocher, G.P., Wypij, D., Perceptions of medical compliance in children and adolescents with cystic fibrosis (1991) J Dev Behav Pediatr, 12 (4), pp. 236-242. , http://dx.doi.org/10.1097/00004703-199108000-00004, PMid:1939678 Modi, A.C., Quittner, A.L., Barriers to treatment adherence for children with cystic fibrosis and asthma: What gets in the way? (2006) J Pediatr Psychol, 31 (8), pp. 846-858. , http://dx.doi.org/10.1093/jpepsy/jsj096, PMid:16401680 Dalcin Pde, T., Rampon, G., Pasin, L.R., Ramon, G.M., Abrahão, C.L., Oliveira, V.Z., Adherence to treatment in patients with cystic fibrosis (2007) J Bras Pneumol, 33 (6), pp. 663-670. , PMid:18200366 Eakin, M.N., Bilderback, A., Boyle, M.P., Mogayzel, P.J., Riekert, K.A., Longitudinal association between medication adherence and lung health in people with cystic fibrosis (2011) J Cyst Fibros, 10 (4), pp. 258-264. , http://dx.doi.org/10.1016/j.jcf.2011.03.005, PMid:21458391 PMCid:3114200 Briesacher, B.A., Quittner, A.L., Saiman, L., Sacco, P., Fouayzi, H., Quittell, L.M., Adherence with tobramycin inhaled solution and health care utilization (2011) BMC Pulm Med, 11, p. 5. , http://dx.doi.org/10.1186/1471-2466-11-5, PMid:21251275 PMCid:3033861 Shinkai, M., Rubin, B.K., Macrolides and airway inflammation in children (2005) Paediatr Respir Rev, 6 (3), pp. 227-235. , http://dx.doi.org/10.1016/j.prrv.2005.06.005, PMid:16153572 Kudoh, S., Uetake, T., Hagiwara, K., Hirayama, M., Hus, L.H., Kimura, H., Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis (1987) Nihon Kyobu Shikkan Gakkai Zasshi, 25 (6), pp. 632-642. , Article in Japanese, PMid:3682440 McArdle, J.R., Talwalkar, J.S., Macrolides in cystic fibrosis (2007) Clin Chest Med, 28 (2), pp. 347-360. , http://dx.doi.org/10.1016/j.ccm.2007.02.005, PMid:17467553 Equi, A., Balfour-Lynn, I.M., Bush, A., Rosenthal, M., Long term azithromycin in children with cystic fibrosis: A randomised, placebo-controlled crossover trial (2002) Lancet, 360 (9338), pp. 978-984. , http://dx.doi.org/10.1016/S0140-6736(02)11081-6 Saiman, L., Marshall, B.C., Mayer-Hamblett, N., Burns, J.L., Quittner, A.L., Cibene, D.A., Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: A randomized controlled trial (2003) JAMA, 290 (13), pp. 1749-1756. , http://dx.doi.org/10.1001/jama.290.13.1749, PMid:14519709 Saiman, L., Anstead, M., Mayer-Hamblett, N., Lands, L.C., Kloster, M., Hocevar-Trnka, J., Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: A randomized controlled trial (2010) JAMA, 303 (17), pp. 1707-1715. , http://dx.doi.org/10.1001/jama.2010.563, PMid:20442386 Cai, Y., Chai, D., Wang, R., Bai, N., Liang, B.B., Liu, Y., Effectiveness and safety of macrolides in cystic fibrosis patients: A meta-analysis and systematic review (2011) J Antimicrob Chemother, 66 (5), pp. 968-978. , http://dx.doi.org/10.1093/jac/dkr040, PMid:21393178 Southern, K.W., Barker, P.M., Solis-Moya, A., Patel, L., Macrolide antibiotics for cystic fibrosis (2011) Cochrane Database Syst Rev, (12), pp. CD002203. , PMid:22161368 Smith, A.L., Fiel, S.B., Mayer-Hamblett, N., Ramsey, B., Burns, J.L., Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: Lack of association in cystic fibrosis (2003) Chest, 123 (5), pp. 1495-1502. , http://dx.doi.org/10.1378/chest.123.5.1495, PMid:12740266 Aaron, S.D., Vandemheen, K.L., Ferris, W., Fergusson, D., Tullis, E., Haase, D., Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: A randomised, double-blind, controlled clinical trial (2005) Lancet, 366 (9484), pp. 463-471. , http://dx.doi.org/10.1016/S0140-6736(05)67060-2 Cantón, R., Cobos, N., de Gracia, J., Baquero, F., Honorato, J., Gartner, S., Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients (2005) Clin Microbiol Infect, 11 (9), pp. 690-703. , http://dx.doi.org/10.1111/j.1469-0691.2005.01217.x, PMid:16104983 Saiman, L., Mehar, F., Niu, W.W., Neu, H.C., Shaw, K.J., Miller, G., Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation (1996) Clin Infect Dis, 23 (3), pp. 532-537. , http://dx.doi.org/10.1093/clinids/23.3.532, PMid:8879776 Merlo, C.A., Boyle, M.P., Diener-West, M., Marshall, B.C., Goss, C.H., Lechtzin, N., Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis (2007) Chest, 132 (2), pp. 562-568. , http://dx.doi.org/10.1378/chest.06-2888, PMid:17646236 Lechtzin, N., John, M., Irizarry, R., Merlo, C., Diette, G.B., Boyle, M.P., Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa (2006) Respiration, 73 (1), pp. 27-33. , http://dx.doi.org/10.1159/000087686, PMid:16113513